RBC-bound nucleic acid diagnostics for earlier detection
Senticell's diagnostic platform analyzes red cell-bound nucleic acids for molecular signals across oncology and infectious disease programs, positioned as a next-generation liquid biopsy approach complementary to plasma-based cfDNA tests. Program details: https://www.senticell.bio/programs.